These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7968783)

  • 21. Attention-deficit/hyperactivity disorder: focus on pharmacologic management.
    Reitz SJ
    J Pediatr Health Care; 1997; 11(2):78-83. PubMed ID: 9155352
    [No Abstract]   [Full Text] [Related]  

  • 22. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
    [No Abstract]   [Full Text] [Related]  

  • 23. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder.
    Grcevich S; Rowane WA; Marcellino B; Sullivan-Hurst S
    J Child Adolesc Psychopharmacol; 2001; 11(1):35-41. PubMed ID: 11322743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
    Kalb C
    Newsweek; 2000 Mar; 135(10):53. PubMed ID: 10847892
    [No Abstract]   [Full Text] [Related]  

  • 26. A clinican's guide to adult attention-deficit hyperactivity disorder.
    Modesto-Lowe V; Meyer A; Soovajian V
    Conn Med; 2012 Oct; 76(9):517-23. PubMed ID: 23155670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs for ADHD.
    Med Lett Drugs Ther; 2020 Jan; 62(1590):9-15. PubMed ID: 31999670
    [No Abstract]   [Full Text] [Related]  

  • 28. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
    Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
    J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
    Faraone SV; Wigal SB; Hodgkins P
    J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BPD and ADHD.
    Lombardo GT
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):719-20. PubMed ID: 9183120
    [No Abstract]   [Full Text] [Related]  

  • 31. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting.
    Swanson J; Wigal S; Greenhill L; Browne R; Waslick B; Lerner M; Williams L; Flynn D; Agler D; Crowley KL; Fineberg E; Regino R; Baren M; Cantwell D
    Psychopharmacol Bull; 1998; 34(1):55-60. PubMed ID: 9564199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A reply to critics of using stimulants to treat attention deficit hyperactivity disorder.
    Pliszka SR
    Tex Med; 1991 Apr; 87(4):84-7. PubMed ID: 1674631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to 'Psychostimulants, adult attention deficit hyperactivity disorder and morbid jealousy'.
    Paterson R
    Aust N Z J Psychiatry; 2000 Oct; 34(5):874-5. PubMed ID: 11037381
    [No Abstract]   [Full Text] [Related]  

  • 35. Attention deficit/hyperactivity disorder. A guide to diagnosis and treatment.
    Nemethy MA
    Adv Nurse Pract; 1997 Feb; 5(2):22-5, 29. PubMed ID: 9459862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAP guideline on treatment of children with ADHD. American Academy of Pediatrics.
    Chatfield J;
    Am Fam Physician; 2002 Feb; 65(4):726, 728. PubMed ID: 11871686
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of Adderall in ADHD.
    Diller LH
    J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):2. PubMed ID: 9893403
    [No Abstract]   [Full Text] [Related]  

  • 38. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis.
    Faraone SV; Biederman J
    J Atten Disord; 2002 Sep; 6(2):69-75. PubMed ID: 12142863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medications for adolescents with attention-deficit/hyperactivity disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2008 Aug; 19(2):254-67, viii-ix. PubMed ID: 18822831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.